Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

John Baptiste

Physician Assistant Brookline, MA Physician Assistant

NPI 1508207911 CMS profile 10511781

48 Lancaster Ter Apt 1, Brookline, MA 02446

Open in the dashboard

General payments

$252

5 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, John Baptiste of Brookline, MA is reported in the CMS Open Payments database as having received $252 across 5 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 43rd percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $23 1
2021 General $228 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Baptiste
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to John Baptiste were reported at $23. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year John Baptiste Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $228 $132 $37–$438 $132
2022 $0 $155 $48–$522 $149
2023 $0 $167 $52–$557 $160
2024 $0 $178 $55–$600 $164
2025 $23 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. DePuy Synthes Sales Inc. $186 2 payments
  2. Medical Device Business Services, Inc. $42 2 payments
  3. Heraeus Medical, LLC. $23 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $137 4 payments
  2. Travel and Lodging $115 1 payment
Products named General payments · program years 2021–2025
  1. Velys $42 2 payments
  2. PALACOS $23 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

712

Median for Physician Assistant: 241

Drug cost

$5,352

Median for Physician Assistant: $4,110

Branded share of claims

2.7%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Enoxaparin Sodium Generic 26 $2,056
Oxycodone Hcl Generic 222 $1,396
Naloxone Hcl Generic 11 $631
Celecoxib Generic 61 $437
Amoxicillin Generic 191 $248
Mupirocin Generic 26 $153
Ondansetron Odt Ondansetron Brand 19 $146
Folic Acid Generic 26 $92
Meloxicam Generic 49 $68
Tramadol Hcl Generic 21 $68

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 25 billing codes

Paid by Medicare

$41,370

Of which drugs: $21,152

Medicare patients

173

Average age 76

Services billed

973

105 women, 68 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 31%
Ischemic heart disease 31%
Chronic kidney disease 29%
Depression 23%
Cancer 21%
Osteoporosis 21%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose J7324 Office 40 111 $10,668
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose J7323 Office 26 84 $7,651
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 20 208 $162

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

5 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record